Serono Symposia International Foundation – Trademark Portfolio
Entity Type: 11
Serono Symposia International Foundation holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 3 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 5 Nice Classification classes. The owner is based in Geneve.
14 rue du Rhone
Geneve 1204 , CH
Showing of trademarks Trademarks
Trademark Classifications
Serono Symposia International Foundation's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Serono Symposia International Foundation have?
Serono Symposia International Foundation has 3 U.S. trademarks filed with the USPTO.
What trademark classes does Serono Symposia International Foundation file in?
Serono Symposia International Foundation files trademarks across 5 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 16 (Paper Goods), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What is Serono Symposia International Foundation's trademark registration success rate?
Serono Symposia International Foundation has a 0% trademark registration rate, with 0 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.